Versant Venture Management, LLC Monte Rosa Therapeutics, Inc. Transaction History
Versant Venture Management, LLC
- $56.3 Million
- Q2 2025
A detailed history of Versant Venture Management, LLC transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Versant Venture Management, LLC holds 5,652,922 shares of GLUE stock, worth $25.2 Million. This represents 45.25% of its overall portfolio holdings.
Number of Shares
5,652,922
Previous 5,652,922
-0.0%
Holding current value
$25.2 Million
Previous $26.2 Million
2.8%
% of portfolio
45.25%
Previous 54.61%
Shares
1 transactions
Others Institutions Holding GLUE
# of Institutions
114Shares Held
58.3MCall Options Held
56.3KPut Options Held
0-
Nea Management Company, LLC Timonium, MD7.69MShares$34.2 Million2.88% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.33MShares$28.1 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA5.66MShares$25.2 Million1.0% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$21.9 Million0.22% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.73MShares$16.6 Million0.31% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $208M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...